Rivaroxaban versus nadroparin for thromboprophylaxis following thoracic surgery for lung cancer: A randomized, noninferiority trial.
Zhao M, Bao Y, Jiang C, Chen L, Xu L, Liu X, Li J, Yang Y, Jiang G, Li J, She Y, Chen Q, Shen L, Chen C.
Zhao M, et al. Among authors: chen l, chen q, chen c.
Am J Hematol. 2023 Aug;98(8):1185-1195. doi: 10.1002/ajh.26945. Epub 2023 May 4.
Am J Hematol. 2023.
PMID: 37139837
Free article.
Clinical Trial.